Clinical trial
Angiogenesis Markers in Primiparas Versus Multiparas: Relevance to Preeclampsia…
NCT00262093 · Hadassah Medical Organization, Other · Unknown status
Key facts
| NCT number | NCT00262093 |
|---|---|
| Title | Angiogenesis Markers in Primiparas Versus Multiparas: Relevance to Preeclampsia Incidence |
| Official title | Angiogenesis Markers in Primiparas Versus Multiparas: Relevance to Preeclampsia Incidence |
| Lead sponsor | Hadassah Medical Organization, Other |
| Collaborators | Beth Israel Deaconess Medical Center |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Pre-Eclampsia |
| Enrollment | 200 |
| Start date | Nov 1, 2005 |
| First posted | Dec 6, 2005 |
| Last update posted | Mar 20, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: